Table of Contents Author Guidelines Submit a Manuscript
Autoimmune Diseases
Volume 2012 (2012), Article ID 876456, 4 pages
http://dx.doi.org/10.1155/2012/876456
Review Article

Vascular Disease in Systemic Lupus Erythematosus

2nd Propedeutic Department of Internal Medicine, Hippokration General Hospital, Konstantinoupoleos 49, 54643 Thessaloniki, Greece

Received 29 April 2012; Accepted 3 August 2012

Academic Editor: Tatiana S. Rodriguez-Reyna

Copyright © 2012 Athina Pyrpasopoulou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. I. Burgos, G. McGwin Jr., J. D. Reveille, L. M. Vilá, and G. S. Alarcón, “Factors predictive of thrombotic events in LUMINA, a multi-ethnic cohort of SLE patients (LXXII),” Rheumatology, vol. 49, no. 9, pp. 1720–1725, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. D. P. M. Symmons and S. E. Gabriel, “Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE,” Nature Reviews Rheumatology, vol. 7, no. 7, pp. 399–408, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. B. J. Skaqqs, B. H. Hahn, and M. McMahon, “Accelerated atherosclerosis in patients with SLE-mechanisms and management,” Nature Reviews Rheumatology, vol. 8, no. 4, pp. 214–223, 2012. View at Google Scholar
  4. I. N. Bruce, “‘Not only...but also’: factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus,” Rheumatology, vol. 44, no. 12, pp. 1492–1502, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. M. B. Urowitz, D. Gladman, D. Ibañez et al., “Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus,” Arthritis Care and Research, vol. 62, no. 6, pp. 881–887, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Benqtsson, M. L. Ohman, O. Nived, and S. Rantapää Dahlqvist, “Cadiovascular event in systemic lupus erythematosus in northern Sweden: incidence and predictors in a 7-year follow-up study,” Lupus, vol. 21, no. 4, pp. 452–459, 2012. View at Google Scholar
  7. J. M. Kahlenberg and M. J. Kaplan, “The interplay of inflammation and cardiovascular disease in systemic lupus erythematosus,” Arthritis Research & Therapy, vol. 13, article 203, 2011. View at Google Scholar
  8. E. Somers, L. S. Magder, and M. Petri, “Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus,” Journal of Rheumatology, vol. 29, no. 12, pp. 2531–2536, 2002. View at Google Scholar · View at Scopus
  9. C. C. Chiu, C. C. Huang, W. L. Chan et al., “Increased risk of ischemic stroke in patients with systemic lupus erythematosus: a nationwide population-based study,” Internal Medicine, vol. 51, no. 1, pp. 17–21, 2012. View at Publisher · View at Google Scholar
  10. J. Romero-Díaz, F. Vargas-Vóracková, E. Kimura-Hayama, L. F. Cortázar-Benítez, R. Gijón-Mitre, S. Criales et al., “Systemic lupus erythematosus risk factors for coronary artery calcifications,” Rheumatology, vol. 51, no. 1, pp. 110–119, 2012. View at Publisher · View at Google Scholar
  11. C. Jurcut, S. Caraiola, D. Nitescu et al., “Subclinical vascular disease in patients with systemic lupus erythematosus: the additive deleterious effect of the antiphospholipidsyndrome,” Joint Bone Spine. In press.
  12. M. B. Urowitz, A. A. Bookman, B. E. Koehler, D. A. Gordon, H. A. Smythe, and M. A. Ogryzlo, “The bimodal mortality pattern of systemic lupus erythematosus,” American Journal of Medicine, vol. 60, no. 2, pp. 221–225, 1976. View at Publisher · View at Google Scholar
  13. G. Chehab, R. Fischer-Betz, and M. Schneider, “Changes in mortality and morbidity in systemic lupus eythematosus,” Zeitschrift für Rheumatologie, vol. 70, no. 6, pp. 480–485, 2011. View at Google Scholar
  14. M. McMahon, B. H. Hahn, and B. J. Skaggs, “Systemic lupus erythematosus and cardiovascular disease: prediction and potential for therapeutic intervention,” Expert Review of Clinical Immunology, vol. 7, no. 2, pp. 227–241, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. S. A. Croca and A. Rahman, “Imaging assessment of cardiovascular disease in systemic lupus erythematosus,” Clinical and Developmental Immunology, vol. 2012, Article ID 694143, 7 pages, 2012. View at Publisher · View at Google Scholar
  16. N. S. Wade and A. S. Major, “The problem of accelerated atherosclerosis in systemic lupus erythematosus: insights into a complex co-morbidity,” Thrombosis and Haemostasis, vol. 106, no. 5, pp. 849–857, 2011. View at Publisher · View at Google Scholar
  17. E. M. Zardi and A. Afeltra, “Endothelial dysfunction and vascular stiffness in systemic lupus erythematosus: are they early markers of subclinical atherosclerosis?” Autoimmunity Reviews, vol. 9, no. 10, pp. 684–686, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. C. A. Roldan, J. Joson, C. R. Qualls, J. Sharrar, and W. L. Sibbitt Jr., “Premature aortic stiffness in systemic lupus erythematosus by transesophageal echocardiography,” Lupus, vol. 19, no. 14, pp. 1599–1605, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Sherer, H. Zinger, and Y. Shoenfeld, “Atherosclerosis in systemic lupus erythematosus,” Autoimmunity, vol. 43, no. 1, pp. 98–102, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. J. L. Rodriquez-Garcia, M. L. Bertolaccini, M. J. Quadrado, G. Sanna, O. Ateka-Barrutia, and M. A. Khamashta, “Clinical manifestations of antiphospholipid syndrome (APS) with and without antiphospholipid antibodies (the so-called “seronegativeAPS”),” Annals of the Rheumatic Diseases, vol. 71, no. 2, pp. 242–244, 2012. View at Google Scholar
  21. X. Deng and X. Liu, “Reevaluation of predictive value of ACL and anti-β2GP1 antibody for thrombosis in patients with systemic lupus erythematosus: from a perspective of a practical world,” Rheumatology International. In press. View at Publisher · View at Google Scholar
  22. J. Frostegård, “Systemic lupus erythematosus and cardiovascular disease,” Lupus, vol. 17, no. 5, pp. 364–367, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. P. L. Meroni, M. O. Borqhi, E. Raschi, and F. Tedesco, “Pathogenesis of antiphospholipd syndrome: understanding the antibodies,” Nature Reviews Rheumatology, vol. 7, no. 6, pp. 330–339, 2011. View at Google Scholar
  24. G. R. V. Hughes, “Hughes Syndrome (the antiphospholipid syndrome). Ten clinical lessons,” Autoimmunity Reviews, vol. 7, no. 3, pp. 262–266, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Ruffatti, T. Del Ross, M. Ciprian et al., “Risk factors for a first thrombotic event in antiphospholipid antibody carriers: a prospective multicentre follow-up study,” Annals of the Rheumatic Diseases, vol. 70, no. 6, pp. 1083–1086, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Pyrpasopoulou, A. Triantafyllou, P. Anyfanti, S. Douma, and S. Aslanidis, “Capillaroscopy as a screening test for clinical antiphospholipid syndrome,” European Journal of Internal Medicine, vol. 22, no. 6, pp. e158–e159, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. P. R. Criado, E. A. Rivitti, M. N. Sotto et al., “Livedoid vasculopathy: an intriguing cutaneous disease,” Anais Brasileiros de Dermatologia, vol. 86, no. 5, pp. 961–977, 2011. View at Publisher · View at Google Scholar
  28. T. Yasue, “Livedoid vasculitis and central nervous system involvement in systemic lupus erythematosus,” Archives of Dermatology, vol. 122, no. 1, pp. 66–70, 1986. View at Google Scholar · View at Scopus
  29. B. Sopeña, M. T. Pérez-Rodríguez, A. Rivera, J. A. Ortiz-Rey, J. Lamas, and M. C. Freire-Dapena, “Livedoid vasculopathy and recurrent thrombosis in a patient with lupus: seronegative antiphospholipid syndrome?” Lupus, vol. 19, no. 11, pp. 1340–1343, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Shimizu, A. Tamura, M. Yamanaka, H. Amano, Y. Nagai, and O. Ishikawa, “Case of livedoid vasculopathy with extensive dermal capillary thrombi,” Journal of Dermatology, vol. 37, no. 1, pp. 94–97, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Khenifer, L. Thomas, B. Balme, and S. Dalle, “Livedoid vasculopathy: thrombotic or inflammatory disease?” Clinical and Experimental Dermatology, vol. 35, no. 7, pp. 693–698, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. P. Cieślik, A. Hrycek, and P. Kłuciński, “Vasculopathy and vasculitis in systemic lupus erythematosus,” Polskie Archiwum Medycyny Wewnetrznej, vol. 118, no. 1-2, pp. 57–63, 2008. View at Google Scholar · View at Scopus
  33. P. Guilpain and L. Mouthon, “Antiendothelial cells autoantibodies in vasculitis-associated systemic diseases,” Clinical Reviews in Allergy and Immunology, vol. 35, no. 1-2, pp. 59–65, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. Renaudineau, C. Dugué, M. Dueymes, and P. Youinou, “Antiendothelial cell antibodies in systemic lupus erythematosus,” Autoimmunity Reviews, vol. 1, no. 6, pp. 365–372, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Praprotnik, M. Blank, P. L. Meroni, B. Rozman, A. Eldor, and Y. Shoenfeld, “Classification of anti-endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells,” Arthritis & Rheumatism, vol. 44, pp. 1484–1494, 2001. View at Google Scholar
  36. M. Galeazzi, G. Morozzi, G. D. Sebastiani et al., “Anti-neutrophil cytoplasmic antibodies in 566 European patients with systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies,” Clinical and Experimental Rheumatology, vol. 16, no. 5, pp. 541–546, 1998. View at Google Scholar · View at Scopus
  37. M. Dobre, J. Wish, and L. Negrea, “Hydralazine-induced ANCA-positive pauci-immune glomerulonephritis: a case report and literature review,” Renal Failure, vol. 31, no. 8, pp. 745–748, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. T. Avcin, M. Canova, P. Guilpain et al., “Infections, connective tissue diseases and vasculitis,” Clinical and Experimental Rheumatology, vol. 26, no. 1, supplement 48, pp. S18–S26, 2008. View at Google Scholar · View at Scopus
  39. H. Hashimoto, S. Maekawa, H. Nasu, T. Okada, Y. Shiokawa, and Y. Fukuda, “Systemic vascular lesions and prognosis in systemic lupus eryhtematosus,” Scandinavian Journal of Rheumatology, vol. 13, no. 1, pp. 45–55, 1984. View at Publisher · View at Google Scholar
  40. P. Soltész, G. Kerekes, H. Dér et al., “Comparative assessment of vascular function in autoimmune rheumatic diseases: considerations of prevention and treatment,” Autoimmunity Reviews, vol. 10, no. 7, pp. 416–425, 2011. View at Publisher · View at Google Scholar · View at Scopus